Cholesterol supplementation objectively reduces photosensitivity in the Smith-Lemli-Opitz syndrome

R M Azurdia; A V Anstey; L E Rhodes

doi:10.1046/j.1365-2133.2001.03964.x

Cholesterol supplementation objectively reduces photosensitivity in the Smith-Lemli-Opitz syndrome

Br J Dermatol. 2001 Jan;144(1):143-5. doi: 10.1046/j.1365-2133.2001.03964.x.

Authors

R M Azurdia¹, A V Anstey, L E Rhodes

Affiliation

¹ Photobiology Unit, Department of Dermatology, Royal Liverpool University Hospital, Prescot Street, Liverpool L7 8XP, UK.

PMID: 11167696
DOI: 10.1046/j.1365-2133.2001.03964.x

Abstract

Smith-Lemli-Opitz (SLO) affected children have multiple congenital physical and mental abnormalities; photosensitivity to ultraviolet A (UVA) has recently become a recognized feature. We present a patient with SLO and prominent photosensitivity in whom detailed phototesting has been performed at baseline and following 6 months of cholesterol supplementation. There was significant improvement in the symptoms of photosensitivity, confirmed objectively by phototesting and accompanied by partial correction of the biochemical abnormalities seen in SLO. This case report is the first to show that cholesterol supplementation in SLO can lead to an objective improvement in the associated photosensitivity.

Publication types

Case Reports

MeSH terms

Adult
Cholesterol, Dietary / therapeutic use*
Dietary Supplements*
Follow-Up Studies
Humans
Male
Photosensitivity Disorders / diet therapy*
Smith-Lemli-Opitz Syndrome / diet therapy*

Substances

Cholesterol, Dietary